Using aptamers for cancer biomarker discovery

Journal of Nucleic Acids

Volumn 2013, Issue , 2013, Pages

  Chang, Yun Min ^a   Donovan, Michael J ^b   Tan, Weihong ^a,b  

^a University of Florida ^*  (United States)

^b HUNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CELL MEMBRANE PROTEIN; MATRIX PROTEIN; NANOPARTICLE; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BINDING AFFINITY; CANCER CELL; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; CELL FUNCTION; CELL SURFACE; COMBINATORIAL CHEMISTRY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; EARLY DIAGNOSIS; GENE MUTATION; GENOTYPE; HUMAN; IMAGING SYSTEM; LUNG CANCER; MICROARRAY ANALYSIS; MICROFLUIDIC ANALYSIS; MOLECULAR DIAGNOSIS; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW;

EID: 84873358481     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.1155/2013/817350     Document Type: Review

References (42)

1. Medley C. D., Bamrungsap S., Tan W., Smith J. E., Aptamer-conjugated nanoparticles for cancer cell detection. Analytical Chemistry 2011 83 3 727 734 2-s2.0-79952140378 10.1021/ac102263v
2. Temsamani J., Vidal P., The use of cell-penetrating peptides for drug delivery. Drug Discovery Today 2004 9 23 1012 1019 10.1016/S1359-6446(04)03279-9 (Pubitemid 39574557)
3. Hahn W. C., Counter C. M., Lundberg A. S., Beijersbergen R. L., Brooks M. W., Weinberg R. A., Creation of human tumour cells with defined genetic elements. Nature 1999 400 6743 464 468 10.1038/22780 (Pubitemid 29361801)
4. Bates P. J., Laber D. A., Miller D. M., Thomas S. D., Trent J. O., Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Experimental and Molecular Pathology 2009 86 3 151 164 2-s2.0-67349167635 10.1016/j.yexmp.2009.01.004
5. Merit Reyes-Reyes E., Teng Y., Bates P. J., A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer Research 2010 70 21 8617 8629 10.1158/0008-5472.CAN-10-0920
6. Sayyed S. G., Hägele H., Kulkarni O. P., Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 2009 52 11 2445 2454 10.1007/s00125-009-1493-6
7. Darisipudi M. N., Kulkarni O. P., Sayyed S. G., Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. The American Journal of Pathology 2011 179 1 116 124 10.1016/j.ajpath.2011.03.004
8. Keefe A. D., Pai S., Ellington A., Aptamers as therapeutics. Nature Reviews Drug Discovery 2010 9 7 537 550 2-s2.0-77955128541 10.1038/nrd3249
9. Hwang D., Ko H., Lee J., Kang H., Ryu S., Song I., Lee D., Kim S., A nucelolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. Journal of Nuclear Medicine 2010 51 98 105 10.2967/jnumed. 109. 069880
10. Fang X., Tan W., Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Accounts of Chemical Research 2010 43 1 48 57 10.1021/ar900101s
11. Henry N. L., Hayes D. F., Cancer biomarkers. Molecular Oncology 2012 6 2 140 146 10.1016/j.molonc.2012.01.010
12. Mann M., Jensen O. N., Proteomic analysis of post-translational modifications. Nature Biotechnology 2003 21 3 255 261 2-s2.0-0037338365 10.1038/nbt0303-255 (Pubitemid 36314808)
13. Hancock W., Apffel A., Chakel J., Hahnenberger K., Choudhary G., Traina J. A., Pungor E., Integrated genomic/proteomic analysis. Analytical Chemistry 1999 71 21 742A 748A 2-s2.0-0033230915 (Pubitemid 29521804)
14. Gold L., Ayers D., Bertino J., Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 2010 5 11, artcile e15004 10.1371/journal.pone.0015004
15. Sefah K., Shangguan D., Xiong X., O'Donoghue M. B., Tan W., Development of DNA aptamers using Cell-SELEX. Nature Protocols 2010 5 6 1169 1185 10.1038/nprot.2010.66
16. Shangguan D., Cao Z., Meng L., Mallikaratchy P., Sefah K., Wang H., Li Y., Tan W., Cell-specific aptamer probes for membrane protein elucidation in cancer cells. Journal of Proteome Research 2008 7 5 2133 2139 2-s2.0-46049086644 10.1021/pr700894d
17. Shangguan D., Li Y., Tang Z., Cao Z. C., Chen H. W., Mallikaratchy P., Sefah K., Yang C. J., Tan W., Aptamers evolved from live cells as effective molecular probes for cancer study. Proceedings of the National Academy of Sciences of the United States of America 2006 103 32 11838 11843 2-s2.0-33747053632 10.1073/pnas.0602615103 (Pubitemid 44215773)
18. Daniels D. A., Chen H., Hicke B. J., Swiderek K. M., Gold L., A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15416 15421 2-s2.0-0347364648 10.1073/pnas.2136683100 (Pubitemid 38021004)
19. Chiquet-Ehrismann R., Mackie E. J., Pearson C. A., Sakakura T., Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986 47 1 131 139 2-s2.0-0022972814 (Pubitemid 17181535)
20. Yoshida J., Wakabayashi T., Okamoto S., Kimura S., Washizu K., Kiyosawa K., Mokuno K., Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour. Journal of Neurology, Neurosurgery and Psychiatry 1994 57 10 1212 1215 2-s2.0-0028076291 (Pubitemid 24321092)
21. Wilson K. E., Langdon S. P., Lessells A. M., Miller W. R., Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. British Journal of Cancer 1996 74 7 999 1004 2-s2.0-0029763767 (Pubitemid 26333897)
22. Ostroff R. M., Bigbee W. L., Franklin W., Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS ONE 2010 5 12, article e15003 10.1371/journal.pone.0015003
23. Kunii T., Ogura S. I., Mie M., Kobatake E., Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX. Analyst 2011 136 7 1310 1312 2-s2.0-79952599370 10.1039/c0an00962h
24. Cavalier-Smith T., Hirt R. P., Horner D. S., Membranome and membrane heredity in development and evolution. Organelles, Genomes and Eukaryote Phylogeny an Evolutionary Synthesis in the Age of Genomics 2012
25. Ghosh D., Beavis R. C., Wilkins J. A., The identification and characterization of membranome components. Journal of Proteome Research 2008 7 4 1572 1583 2-s2.0-45549091555 10.1021/pr070509u
26. Dua P., Kim S., Lee D. K., Nucleic acid aptamers targeting cell-surface proteins. Methods 2011 54 2 215 225 2-s2.0-79958744392 10.1016/j.ymeth.2011.02. 002
27. Tanaka F., Yoneda K., Kondo N., Hashimoto M., Takuwa T., Matsumoto S., Okumura Y., Circulating tumor cell as a diagnostic marker in primary lung cancer. Clinical Cancer Research 2009 15 22 6980 6986 10.1158/1078-0432.CCR-09- 1095
28. Cen P., Ni X., Yang J., Graham D. Y., Li M., Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochimica et Biophysica Acta 2012 1826 2 350 356 10.1016/j.bbcan.2012.05.007
29. Welsh J. B., Sapinoso L. M., Kern S. G., Brown D. A., Liu T., Bauskin A. R., Ward R. L., Hawkins N. J., Quinn D. I., Russell P. J., Sutherland R. L., Breit S. N., Moskaluk C. A., Frierson H. F., Hampton G. M., Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proceedings of the National Academy of Sciences of the United States of America 2003 100 6 3410 3415 2-s2.0-0037452997 10.1073/pnas.0530278100 (Pubitemid 36356597)
30. Medley C. D., Bamrungsap S., Tan W., Smith J. E., Aptamer-conjugated nanoparticles for cancer cell detection. Analytical Chemistry 2011 83 3 727 734 2-s2.0-79952140378 10.1021/ac102263v
31. Mayer G., Ahmed M. S. L., Dolf A., Endl E., Knolle P. A., Famulok M., Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nature Protocols 2010 5 12 1993 2004 2-s2.0-78649979777 10.1038/nprot.2010.163
32. Douglas S. M., Bachelet I., Church G. M., A logic-gated nanorobot for transport of molecular payload. Science 2012 355 6070 831 834 10.1126/science.1214081
33. Sangguan D., Li Y., Tang Z., Aptamers evolved from live cells as effective molecular probes for cancer study. Proceedings of the National Academy of Sciences of the United States of America 2006 103 32 11838 11843 10.1073/pnas.0602615103 (Pubitemid 44215773)
34. Bamford S., Dawson E., Forbes S., Clements J., Pettett R., Dogan A., Flanagan A., Teague J., Futreal P. A., Stratton M. R., Wooster R., The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. British Journal of Cancer 2004 91 2 355 358 2-s2.0-3843084078 (Pubitemid 39037083)
35. http://www.sanger.ac.uk/genetics/CGP/cosmic/
36. MacConaill L. E., Campbell C. D., Kehoe S. M., Bass A. J., Hatton C., Niu L., Davis M., Yao K., Hanna M., Mondal C., Luongo L., Emery C. M., Baker A. C., Philips J., Goff D. J., Fiorentino M., Rubin M. A., Polyak K., Chan J., Wang Y., Fletcher J. A., Santagata S., Corso G., Roviello F., Shivdasani R., Kieran M. W., Ligon K. L., Stiles C. D., Hahn W. C., Meyerson M. L., Garraway L. A., Profiling critical cancer gene mutations in clinical tumor samples. PLoS ONE 2009 4 11, article e7887 2-s2.0-70849116358 10.1371/journal.pone.0007887
37. Hammerman P. S., Hayes D. N., Wilkerson M. D., Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012 489 519 525 10.1038/nature11404
38. Cancer T., Atlas G., Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012 487 330 337 10.1038/nature11252
39. McLendon R., Friedman A., Bigner D., Van Meir E. G., Brat D. J., Mastrogianakis G. M., Olson J. J., Mikkelsen T., Lehman N., Aldape K., Yung W. K. A., Bogler O., Weinstein J. N., VandenBerg S., Berger M., Prados M., Muzny D., Morgan M., Scherer S., Sabo A., Nazareth L., Lewis L., Hall O., Zhu Y., Ren Y., Alvi O., Yao J., Hawes A., Jhangiani S., Fowler G., San Lucas A., Kovar C., Cree A., Dinh H., Santibanez J., Joshi V., Gonzalez-Garay M. L., Miller C. A., Milosavljevic A., Donehower L., Wheeler D. A., Gibbs R. A., Cibulskis K., Sougnez C., Fennell T., Mahan S., Wilkinson J., Ziaugra L., Onofrio R., Bloom T., Nicol R., Ardlie K., Baldwin J., Gabriel S., Lander E. S., Ding L., Fulton R. S., McLellan M. D., Wallis J., Larson D. E., Shi X., Abbott R., Fulton L., Chen K., Koboldt D. C., Wendl M. C., Meyer R., Tang Y., Lin L., Osborne J. R., Dunford-Shore B. H., Miner T. L., Delehaunty K., Markovic C., Swift G., Courtney W., Pohl C., Abbott S., Hawkins A., Leong S., Haipek C., Schmidt H., Wiechert M., Vickery T., Scott S., Dooling D. J., Chinwalla A., Weinstock G. M., Mardis E. R., Wilson R. K., Getz G., Winckler W., Verhaak R. G. W., Lawrence M. S., O'Kelly M., Robinson J., Alexe G., Beroukhim R., Carter S., Chiang D., Gould J., Gupta S., Korn J., Mermel C., Mesirov J., Monti S., Nguyen H., Parkin M., Reich M., Stransky N., Weir B. A., Garraway L., Golub T., Meyerson M., Chin L., Protopopov A., Zhang J., Perna I., Aronson S., Sathiamoorthy N., Ren G., Yao J., Wiedemeyer W. R., Kim H., Sek W. K., Xiao Y., Kohane I. S., Seidman J., Park P. J., Kucherlapati R., Laird P. W., Cope L., Herman J. G., Weisenberger D. J., Pan F., Van Den Berg D., Van Neste L., Joo M. Y., Schuebel K. E., Baylin S. B., Absher D. M., Li J. Z., Southwick A., Brady S., Aggarwal A., Chung T., Sherlock G., Brooks J. D., Myers R. M., Spellman P. T., Purdom E., Jakkula L. R., Lapuk A. V., Marr H., Dorton S., Yoon G. C., Han J., Ray A., Wang V., Durinck S., Robinson M., Wang N. J., Vranizan K., Peng V., Van Name E., Fontenay G. V., Ngai J., Conboy J. G., Parvin B., Feiler H. S., Speed T. P., Gray J. W., Brennan C., Socci N. D., Olshen A., Taylor B. S., Lash A., Schultz N., Reva B., Antipin Y., Stukalov A., Gross B., Cerami E., Wei Q. W., Qin L. X., Seshan V. E., Villafania L., Cavatore M., Borsu L., Viale A., Gerald W., Sander C., Ladanyi M., Perou C. M., Hayes D. N., Topal M. D., Hoadley K. A., Qi Y., Balu S., Shi Y., Wu J., Penny R., Bittner M., Shelton T., Lenkiewicz E., Morris S., Beasley D., Sanders S., Kahn A., Sfeir R., Chen J., Nassau D., Feng L., Hickey E., Barker A., Gerhard D. S., Vockley J., Compton C., Vaught J., Fielding P., Ferguson M. L., Schaefer C., Zhang J., Madhavan S., Buetow K. H., Collins F., Good P., Guyer M., Ozenberger B., Peterson J., Thomson E., Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008 455 7216 1061 1068 2-s2.0-54549108740 10.1038/nature07385
40. Koboldt D. C., Fulton R. S., McLellan M. D., Comprehensive molecular portraits of human breast tumours. Nature 2012 1 10 10.1038/nature11412
41. Larman T. C., DePalma S. R., Hadjipanayisa A. G., Spectrum of somatic mitochondrial mutations in five cancers. Proceedings of the National Academy of Sciences of the United States of America 2012 109 14087 14091 10.1073/pnas.1211502109
42. http://cancergenome.nih.gov/abouttcga/policies/publicationguidelines